Cargando…

Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies

BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ellen, Husein, Adnan, Martinez-Perez, Jose, Li, Terrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984739/
https://www.ncbi.nlm.nih.gov/pubmed/35399911
http://dx.doi.org/10.1155/2022/1068227
_version_ 1784682247931035648
author Yang, Ellen
Husein, Adnan
Martinez-Perez, Jose
Li, Terrence
author_facet Yang, Ellen
Husein, Adnan
Martinez-Perez, Jose
Li, Terrence
author_sort Yang, Ellen
collection PubMed
description BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positive for COVID-19 and experienced respiratory symptoms that completely resolved within one week. About 3 weeks after testing positive, he began experiencing acute onset anuria, followed by lower extremity paresthesia and paraparesis, which progressed to bilateral lower extremity paraplegia, complete loss of sensation of pain, temperature, vibration, and proprioception, and a T4 sensory level. He was initially diagnosed with and treated for acute inflammatory demyelinating polyradiculoneuropathy (AIDP), after which he made minimal clinical improvement. The diagnosis was shifted to longitudinally extensive transverse myelitis, and his CSF tested positive for MOG antibodies. He is being treated with a steroid regimen and extensive outpatient physical therapy. CONCLUSION: The neurologic manifestations of COVID-19 are still being uncovered. Neurologic symptoms should be included in patient education on symptom monitoring, even after recovery of respiratory illness, so that COVID-19-related CNS pathology can be urgently treated.
format Online
Article
Text
id pubmed-8984739
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89847392022-04-07 Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies Yang, Ellen Husein, Adnan Martinez-Perez, Jose Li, Terrence Case Rep Neurol Med Case Report BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positive for COVID-19 and experienced respiratory symptoms that completely resolved within one week. About 3 weeks after testing positive, he began experiencing acute onset anuria, followed by lower extremity paresthesia and paraparesis, which progressed to bilateral lower extremity paraplegia, complete loss of sensation of pain, temperature, vibration, and proprioception, and a T4 sensory level. He was initially diagnosed with and treated for acute inflammatory demyelinating polyradiculoneuropathy (AIDP), after which he made minimal clinical improvement. The diagnosis was shifted to longitudinally extensive transverse myelitis, and his CSF tested positive for MOG antibodies. He is being treated with a steroid regimen and extensive outpatient physical therapy. CONCLUSION: The neurologic manifestations of COVID-19 are still being uncovered. Neurologic symptoms should be included in patient education on symptom monitoring, even after recovery of respiratory illness, so that COVID-19-related CNS pathology can be urgently treated. Hindawi 2022-04-05 /pmc/articles/PMC8984739/ /pubmed/35399911 http://dx.doi.org/10.1155/2022/1068227 Text en Copyright © 2022 Ellen Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yang, Ellen
Husein, Adnan
Martinez-Perez, Jose
Li, Terrence
Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title_full Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title_fullStr Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title_full_unstemmed Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title_short Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
title_sort post-covid-19 longitudinally extensive transverse myelitis with myelin oligodendrocyte glycoprotein antibodies
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984739/
https://www.ncbi.nlm.nih.gov/pubmed/35399911
http://dx.doi.org/10.1155/2022/1068227
work_keys_str_mv AT yangellen postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies
AT huseinadnan postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies
AT martinezperezjose postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies
AT literrence postcovid19longitudinallyextensivetransversemyelitiswithmyelinoligodendrocyteglycoproteinantibodies